IL18R1 and cancer: Between each of the treatment groups and the control, a total of 150 pathways were enriched; the greatest proportion of DEGs are involved in cytokine-receptor interaction, pathways in cancer, hemapoeitc cell linage, leukocyte transendothelial migration, and phagosome pathway (Fig. 4).